BiomX Statistics

Total Valuation

BiomX has a market cap or net worth of $12.99 million. The enterprise value is $8.32 million.

Market Cap	12.99M
Enterprise Value	8.32M

Important Dates

The last earnings date was Wednesday, August 13, 2025, before market open.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

BiomX has 26.18 million shares outstanding. The number of shares has increased by 248.74% in one year.

Current Share Class	26.44M
Shares Outstanding	26.18M
Shares Change (YoY)	+248.74%
Shares Change (QoQ)	+35.52%
Owned by Insiders (%)	5.57%
Owned by Institutions (%)	26.04%
Float	16.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	25.48
P/TBV Ratio	25.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.66, with a Debt / Equity ratio of 0.49.

Current Ratio	2.66
Quick Ratio	2.24
Debt / Equity	0.49
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,711.50

Financial Efficiency

Return on equity (ROE) is -79.71% and return on invested capital (ROIC) is -64.97%.

Return on Equity (ROE)	-79.71%
Return on Assets (ROA)	-40.11%
Return on Invested Capital (ROIC)	-64.97%
Return on Capital Employed (ROCE)	-107.68%
Revenue Per Employee	n/a
Profits Per Employee	-$325,737
Employee Count	57
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BiomX has paid $6,000 in taxes.

Income Tax	6,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.32% in the last 52 weeks. The beta is 1.43, so BiomX's price volatility has been higher than the market average.

Beta (5Y)	1.43
52-Week Price Change	-73.32%
50-Day Moving Average	0.45
200-Day Moving Average	0.61
Relative Strength Index (RSI)	52.42
Average Volume (20 Days)	12,401,122

Short Selling Information

The latest short interest is 326,502, so 1.25% of the outstanding shares have been sold short.

Short Interest	326,502
Short Previous Month	187,789
Short % of Shares Out	1.25%
Short % of Float	2.03%
Short Ratio (days to cover)	0.12

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-34.23M
Pretax Income	-37.11M
Net Income	-18.57M
EBITDA	-32.52M
EBIT	-34.23M
Earnings Per Share (EPS)	-$2.01

Full Income Statement

Balance Sheet

The company has $14.05 million in cash and $9.38 million in debt, giving a net cash position of $4.67 million or $0.18 per share.

Cash & Cash Equivalents	14.05M
Total Debt	9.38M
Net Cash	4.67M
Net Cash Per Share	$0.18
Equity (Book Value)	19.16M
Book Value Per Share	0.02
Working Capital	10.37M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BiomX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-248.74%
Shareholder Yield	-248.74%
Earnings Yield	-142.92%
FCF Yield	n/a

Analyst Forecast

The average price target for BiomX is $15.00, which is 2,922.37% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	2,922.37%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-7.19%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 26, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	Aug 26, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a